Gnubiotics Sciences SA
PrivateLast Round
Grant
Jul 6, 2022
Total Funding Raised
$7.49M
Company Overview
Gnubiotics Sciences SA operates in Healthcare & Life Sciences and is based in Epalinges. Its latest recorded funding round was a Grant round in July 2022.
Gnubiotics Sciences SA is a biotechnology company that develops glycan-based solutions and functional ingredients to improve microbiome health in humans and companion animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gnubiotics Sciences SA Comparables
Compare Gnubiotics Sciences SA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sweetech | 77% | |
| Inbiose | 70% | |
| dsm-firmenich | 68% |
For institutional investors. Book with your work email.
Gnubiotics Sciences SA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 6, 2022 | ||||
| Series A | Jul 30, 2020 | ||||
| Debt | Jul 30, 2020 | ||||
| Convertible Debt | Dec 28, 2017 | ||||
| Accelerator | May 29, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gnubiotics Sciences SA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canton of Vaud | Debt |
| Innosuisse | Grant |
| Venture Kick | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors increased 204% MoM to 1.1K.
- Oct 12, 2024
Monthly visitors grew 202% MoM, reaching 1.3K.
For institutional investors. Book with your work email.
Gnubiotics Sciences SA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gnubiotics Sciences SA's valuation, stock price, and market status.
Is Gnubiotics Sciences SA a public or private company?
Gnubiotics Sciences SA is a private company.
What is the current stock price of Gnubiotics Sciences SA?
Gnubiotics Sciences SA is a private company, so its shares have no public market price. Caplight tracks Gnubiotics Sciences SA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gnubiotics Sciences SA worth (valuation)?
Valuation information for Gnubiotics Sciences SA is not publicly available.
Can I buy Gnubiotics Sciences SA stock?
Gnubiotics Sciences SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gnubiotics Sciences SA's last funding round?
Gnubiotics Sciences SA's most recent funding round was Grant on July 6, 2022.
Who are the main investors in Gnubiotics Sciences SA?
Key investors in Gnubiotics Sciences SA include Canton of Vaud, Innosuisse, Venture Kick.
Will Gnubiotics Sciences SA IPO soon?
No public IPO plans have been announced for Gnubiotics Sciences SA.
How can I track Gnubiotics Sciences SA secondary market activity?
Caplight tracks bids, offers, and trades in Gnubiotics Sciences SA's shares on secondary markets.